Global Pricing & Access Lead, Rare Neurology

Location : Barcelona - Spain (3 days working from the office and 2 days working from home) At Alexion, AstraZeneca Rare Disease , this role offers the opportunity to shape access for transformative medicines in areas of high unmet need and make a meaningful impact for patients living with rare neurological diseases . You will operate in a highly visible, strategic position with broad cross-functional exposure, leading portfolio-level market access, pricing, and reimbursement strategy across key markets, with a particular focus on the NMOSD indication. This is an opportunity for an experienced market access leader to influence critical launch and lifecycle decisions, navigate complex payer environments, and play a central role in advancing our ambition within Neurology . What you’ll will do: Join a highly valued, strategic team that is fundamental to realizing the potential of our life-changing medicines. Through our work, AstraZeneca is able to ensure that appropriate access is provided to our transformative therapies. Alexion, AstraZeneca Rare Disease’s Global Value Access and Pricing ( GVAP ) team is seeking a qualified Director to join a dynamic and growing team, with responsibility for Neurology indications, including near-term new product launches and label expansions. As a key member of the GVAP team, you will help shape and execute global value, access, and pricing strategies across the Neurology portfolio in selected key EU markets , with particular strategic focus on the NMOSD indication and its lifecycle management This is a strategic role that leverages your understanding and application of global healthcare and health technology assessment ( HTA ) systems, competitive insights, and clinical knowledge to shape market access, pricing, and reimbursement success for critical product launches and indications. The ideal candidate for this role will have deep expertise in global payer, HTA , and reimbursement ecosystems, with a strong track record of driving market access, pricing, and reimbursement success within rare diseases and Neurology . You will be responsible for: Value Lead and drive cross-functional development of a clear, differentiated value proposition for NMOSD , while influencing without authority and navigating complex organizational systems. Collaborate with cross-functional teams to ensure that evidence generation plans and real-world evidence ( RWE ) are incorporated effectively to deliver a comprehensive value proposition, reduce uncertainty for payers, and optimize patient access. This includes securing timely country input on endpoints and evidence generation plans in priority target countries. Provide support to the GMMA Commercial team to advance NMOSD lifecycle management (LCM) through governance milestones focused on market access potential, evidence, and target product profile (TPP) requirements. Access Lead development of global market access and pricing strategies - activities and support implementation in close partnership with country access representatives of assigned countries Lead the assessment of pricing and reimbursement ( P&R ) risks and opportunities, and the implementation of corresponding mitigation actions specific to Neurology . Create and roll out strategic value, access, and pricing communication tools and materials for NMOSD to support local P&R submissions and negotiations, such as pricing frameworks, negotiation strategies, and toolkits, in alignment with the enterprise-wide launch framework. Lead the update of the global reimbursement dossier for NMOSD and the overall cross-functional market access readiness plans for Neurology , in close collaboration with key countries and support functions ( HEOR, Medical, and Commercial ). Represent the GVAP perspective and strategy across various cross-functional teams, including the Global Value Sub-Team and Global Launch Team , and provide updates and guidance to local teams as needed. Own the monthly Neurology payer working group to share the latest evidence and drive best practice sharing across countries. Understand and incorporate the patient perspective on the disease, and recommend strategies that support the patient voice in key payer negotiations. Pricing Support the development of the Neurology prici